REQUEST A DEMO
Total
USD $0.00
Search more companies

Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda Profile Updated: March 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda is a company in Ecuador, with a head office in Riobamba. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on October 19, 2009. There are currently 4 (2024) people employed by Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda. The latest financial highlights indicate a net sales revenue increase of 6.23% in 2025. Over the same period, its total assets decreased by 21.82%. In 2025, Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda’s net profit margin increased by 0.63%.

Headquarters
Calle Larrea, 2234
Riobamba; Chimborazo;

Contact Details: Purchase the Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda report to view the information.
Registered Capital:
Purchase the Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda report to view the information.
Financial Auditors:
Purchase the Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda report to view the information.
Incorporation Date:
October 19, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Rivas Laboratorio Farmaceutico Rivalav Cia. Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
6.23%
Total Operating Revenue
6.23%
Operating Profit
119.34%
EBITDA
80.65%
Net Profit/Loss for the Period
132.77%
Total Assets
-21.82%
Total Equity
7.7%
Operating Profit Margin
0.96%
Net Profit Margin
0.63%
Return on Equity (ROE)
3.84%
Debt / Equity
-1.11%
Quick Ratio
0.02%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?